Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli Rosetta (DE3) | Severe acute respiratory syndrome coronavirus 2 |
Crystallization (Comment) | Organism |
---|---|
sitting-drop vapor-diffusion method at 18°C, crystal structures of the enzyme and its complex with YM155 at 2.1 A resolution | Severe acute respiratory syndrome coronavirus 2 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
cryptotanshinone | exhibits strong antiviral activities in cell-based assays | Severe acute respiratory syndrome coronavirus 2 | |
GRL0617 | exhibits strong antiviral activities in cell-based assays | Severe acute respiratory syndrome coronavirus 2 | |
additional information | over 6000 compounds are screened that included approved drugs, drug candidates in clinical trials, and pharmacologically active compounds to identify leads that target the SARS-CoV-2 papain-like protease (PLpro) | Severe acute respiratory syndrome coronavirus 2 | |
tanshinone | exhibits strong antiviral activities in cell-based assays | Severe acute respiratory syndrome coronavirus 2 | |
YM155 | exhibits strong antiviral activities in cell-based assays. YM155 simultaneously targets three hotspots on PLpro, including the substrate-binding pocket, the interferon stimulating gene product 15 (ISG15) binding site and zinc finger motif | Severe acute respiratory syndrome coronavirus 2 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Severe acute respiratory syndrome coronavirus 2 | P0DTD1 | full-length gene encoding SARS-CoV-2 PLpro (residues 1564-1878 of the SARS-CoV-2 polyprotein); SARS-CoV-2 | - |
Purification (Comment) | Organism |
---|---|
- |
Severe acute respiratory syndrome coronavirus 2 |
Synonyms | Comment | Organism |
---|---|---|
PLpro | - |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 papain-like protease | - |
Severe acute respiratory syndrome coronavirus 2 |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00139 | - |
pH 7.5, temperature not specified in the publication, without Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | GRL0617 | |
0.00153 | - |
pH 7.5, temperature not specified in the publication, 0.01% (v/v) Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | tanshinone | |
0.00166 | - |
pH 7.5, temperature not specified in the publication, 0.01% (v/v) Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | GRL0617 | |
0.00183 | - |
pH 7.5, temperature not specified in the publication, 0.01% (v/v) Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | YM155 | |
0.00221 | - |
pH 7.5, temperature not specified in the publication, without Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | tanshinone | |
0.00247 | - |
pH 7.5, temperature not specified in the publication, without Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | YM155 | |
0.00563 | - |
pH 7.5, temperature not specified in the publication, without Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | cryptotanshinone | |
0.00599 | - |
pH 7.5, temperature not specified in the publication, 0.01% (v/v) Triton X-100 | Severe acute respiratory syndrome coronavirus 2 | cryptotanshinone |